ANG-2864

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameANG-2864
Drug Alias NamePARP inhibitor (Angion Biomedica)ANG-2864
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPoly (ADP-Ribose) polymerase 1 inhibitors
TargetsPoly (ADP-Ribose) polymerase 1
Therapy Area/IndicationsIschemiaLiver FailureNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesElicio Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesElicio Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsIschemiaLiver FailureNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A